Use of Registries in Regulatory Decision Making

The C-Path team is working to revolutionize the use of real-world data in sharing the future of medical product development in Europe and invite you to:

  • Stay updated on the latest in registry-based healthcare research and data utilization.
  • Understand the European Medicines Agency’s guidelines for registry-based studies.
  • Explore a compelling case study on registry-based real-world data in the regulatory process.
  • Engage in a dynamic Q&A session with Health Technology Assessment experts and regulators

Register here.